2017 Speaker List

Esther Abels, Director, Quality and Regulatory and Medical Affairs; Emerging Businesses, Philips Digital Pathology Solutions

Edward Abrahams, Ph.D., President, Personalized Medicine Coalition

Nicola Aceto, Ph.D., Assistant Professor, Oncology, Department of Biomedicine, University of Basel

Viktor Adalsteinsson, Ph.D., Group Leader, Broad Institute of MIT and Harvard

Alex J. Adams, Pharm.D., MPH, Executive Director, Idaho State Board of Pharmacy

Chrystal Adams, Assistant Vice President, Product Marketing, XIFIN, Inc.

Daniel Adams, Senior Research Scientist, Creatv MicroTech, Inc.

Neeraj Adya, Ph.D., Director, Pharmacodiagnostics Research and Development, Bristol-Myers Squibb

Greg Alberts, Ph.D., Lonza Walkersville, Inc

Catherine Alix-Panabières, Ph.D., Director, Laboratory of Rare Human Circulating Cells (LCCRH), Cellular and Tissular Biopathology of Cancers, University Medical Center of Montpellier

Robert Anders, M.D., Ph.D., Associate Professor, Pathology, Johns Hopkins

Kristin Ardlie, Ph.D., Director, GTEx LDACC, Broad Institute of Harvard and MIT

Jon Armstrong, CSO, Cofactor Genomics

Alan Ashworth, Ph.D., FRS, President, UCSF Helen Diller Family Comprehensive Cancer Center; Senior Vice President for Cancer Services, UCSF Health Professor Medicine, Division of Hematology/Oncology, Medicine; E. Dixon Heise Distinguished Professor, Oncology, University of California, San Francisco

Don Bailey, Ph.D., Distinguished Fellow, RTI International

Leonora Balaj, Ph.D. Research Fellow, Massachusetts General Hospital, Harvard Medical School

Ulysses G. J. Balis, M.D., FCAP, FASCP, FAIMBE, Professor, Pathology; Director, Division of Pathology Informatics; Director, Pathology Informatics Fellowship Program, Pathology, University of Michigan Health System

Sourav Bandyopadhyay, Ph.D., Assistant Professor, Bioengineering and Therapeutic Sciences, University of California, San Francisco

Mike Barlow, Vice President, Operations, MolDX Executive Lead, Specialty Contracts, Palmetto GBA

Jeffrey S. Barrett, Ph.D., Vice President, Translational Informatics, Sanofi Pharmaceuticals

Geoffrey A. Bartholomeusz, Ph.D., Associate Professor and Director, siRNA Core Facility, Department of Experimental Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

Michael S. Bartsch, Ph.D., Research Engineer, Biotechnology and Bioengineering, Sandia National Laboratories

Michael Bassik, Ph.D., Assistant Professor, Department of Genetics, Stanford University

Sudeep Basu, Ph.D., Practice Leader, TechVision-Innovation Services, Frost & Sullivan

Andrew Beck, Ph.D., Principal Investigator, Pathology, Beth Israel Deaconess Medical Center

Holger Becker, Ph.D., Founder & CSO, microfluidic ChipShop GmbH

Kathryn Becker, Global Marketing Director, Companion Diagnostics, Abbott Molecular

Caroline Beckett, Global CRISPR Product Manager, MilliporeSigma

Kirk Beebe, Ph.D., Director, Applied Metabolomics, Metabolon

Pedro J. Beltran, Ph.D., Research Director, Oncology Research, Amgen, Inc.

Peter Benn, Ph.D., Professor, Genetics and Genome Sciences, University of Connecticut Health Center

David Berz, M.D., Ph.D., MPH, Assistant Professor, Department of Cellular Therapeutics, City of Hope Beckman Research Institute

Myron G. Best, Ph.D. Student, Neurosurgery, Cancer Center Amsterdam, VU University Medical Center Amsterdam, The Netherlands

Chetan Bettegowda, M.D., Ph.D., Assistant Professor, Neurosurgery and Oncology, Johns Hopkins University School of Medicine

Farideh Bischoff, Ph.D., Chief Clinical Development Officer, North America, Menarini Silicon Biosystems

Mark S. Boguski, M.D., Ph.D., Founder & CMO, Precision Medicine Network, Inc.

Ezio Bonvini, M.D., Senior Vice President, Research, MacroGenics, Inc.

Bryan Bothwell, Director, Strategy and Business Development, Qorvo

Michael Brehm, Ph.D., Associate Professor, The Robert and Sandra Glass Term Chair in Diabetes, Diabetes Center of Excellence, Program in Molecular Medicine, University of Massachusetts Medical School

Steven E. Brenner, Ph.D., Professor, Plant & Microbial Biology, University of California, Berkeley

Andrew Brooks, Ph.D., COO, RUCDR Infinite Biologics

Sarah M. Brown, Ph.D., DABCC, Assistant Professor, Pediatrics, and Pathology & Immunology; Washington University in St. Louis School of Medicine; Medical Director, POCT; St. Louis Children’s Hospital

Trevor W. Brown, MSc, Vice President, Precision Medicine, SeraCare Life Sciences, Inc.

Catherine Brownstein, Instructor, Genetics and Genomics, Boston Children’s Hospital and Harvard Medical School

Lynn Bry, M.D., Ph.D., FCAP, Director, Massachusetts Host-Microbiome Center, Pathology, Brigham & Women’s Hospital, Harvard Medical School

Andrew Bryan, M.D., Ph.D., Acting Assistant Professor, Assistant Director, Clinical Microbiology, Department of Laboratory Medicine, University of Washington

Brian Burke, Ph.D., Director, Business Development, Horizon Discovery

Ben Busby, Ph.D., Genomics Outreach Coordinator, NCBI, NLM/NIH

Susan Butler-Wu, Ph.D., D(ABMM), Associate Professor, Clinical Pathology, Keck School of Medicine of the University of Southern California, Director, Clinical Microbiology, LAC+USC Medical Center

George A. Calin, M.D., Ph.D., Professor, Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center

Gerard Cangelosi, Ph.D., Professor, Environmental and Occupational Health Sciences, University of Washington

Cesar M. Castro, M.D., Director, Cancer Program, MGH Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School

Jian Cao, Ph.D., Associate Research Scientist, Department of Pathology, Yale University

Benjamin Casavant, Ph.D., Vice President, Tasso

Lon Castle, M.D., CMO, Molecular Genetics, Specialty Drug and Personalized Medicine, eviCore healthcare

Arijit Chakravarty, Ph.D., Director, Modeling & Simulation (DMPK), Takeda Pharmaceutical International Co.

Timothy A. Chan, M.D., Ph.D., Radiation Oncologist; Vice Chair, Radiation Oncology; Director, Translational Oncology Division; PaineWebber Chair, Cancer Genetics Memorial Sloan Kettering

Pranil K. Chandra, DO, FCAP, FASCP, Assistant Vice President and Medical Director, Molecular Pathology and Genomic Medicine Services, Interim Medical Director, Clinical Pathology Services, PathGroup (AMP Economic Affairs Committee, Member)

Mark Chao, M.D., Ph.D., Co-Founder and Medical Director, Forty Seven Inc.

Zac Chatterton, Ph.D., Postdoctoral Fellow, Neuroscience, Icahn School of Medicine, Mount Sinai

Charles Chiu, M.D., Ph.D., Associate Professor, Lab Medicine and Infectious Diseases; Director, UCSF-Abbott Viral Diagnostics and Discovery Center; Associate Director, Clinical Microbiology Laboratory, University of California, San Francisco

Cheryl-Emiliane Chow, Ph.D., Bioinformatics Scientist Solutions, Second Genome

Melina Cimler, Ph.D., Senior Vice President, Quality & Regulatory, Adaptive Biotechnologies

Anderson Clark, Ph.D., Director, Translational in vivo Pharmacology, Oncology, EMD Serono Research & Development Institute

Rita R. Colwell, Ph.D., D.Sc., Distinguished Professor, Center for Bioinformatics and Computational Biology and University of Maryland Institute of Advance, University of Maryland College Park

Mei Cong, Ph.D., Director, R&D Custom Assay Services, Promega

Nick Conley, Ph.D., CEO & Co-Founder, EpiBiome

Jeffrey Conroy, Senior Vice President, Technology Development, OmniSeq Precision Medicine; Director, Genomic Technologies, Roswell Park Cancer Institute

David Cook, Ph.D., Executive Vice President of R&D and CSO, Seres Health

Mike Costa, Ph.D., Senior Scientific Manager, Department of Discovery Oncology, Genentech Research & Early Development

Peter Covitz, Ph.D., Senior Director, Research & Translational IT, Research and Development IT, Biogen

J. Colin Cox, Ph.D., Science Manager, Genentech

Bruce R. Conklin, M.D., Investigator, Gladstone Institute of Cardiovascular Disease and Professor, Division of Genomic Medicine, University of California, San Francisco

Colleen Cutcliffe, Ph.D., Co-Founder and CEO, Whole Biome

Robert Daber, Ph.D., Vice President, Genomics Operations and Development, Laboratory Medicine, Bio Reference Laboratories

Joseph Dal Porto, Ph.D., Director, Pfizer Center for Therapeutic Innovation

Atti-La Dahlgren, M.D., MPH, Physician, Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet

Adil Daud, M.D., HS Clinical Professor, Medicine (Hematology/Oncology); Director, Melanoma Clinical Research, Helen Diller Comprehensive Cancer Center, University of California, San Francisco

John De Groot, Associate Professor, Chair Ad Interim, Neuro-Oncology, The University of Texas MD Anderson Cancer Center

Matthew De Silva, CEO, Founder, Notable Labs

Josh Deignan, Ph.D., FACMG, Associate Director, UCLA Molecular Diagnostics Laboratories, Pathology and Laboratory Medicine, University of California, Los Angeles

Dino Di Carlo, Ph.D., Professor, Bioengineering, California NanoSystems Institute; Director, Cancer Nanotechnology Program, Jonsson Comprehensive Cancer Center, University of California, Los Angeles

Daniel E. Carvajal-Hausdorf, M.D., Postdoctoral Associate, Pathology, Yale School of Medicine

Luis A. Diaz, M.D., Associate Professor, Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Maximilian Diehn, M.D., Ph.D., Assistant Professor, Radiation Oncology, Stanford Cancer Institute, Institute for Stem Cell Biology & Regenerative Medicine, Stanford University

Jennifer Dien Bard, Director, Clinical Microbiology Laboratory, Assistant Professor, Clinical Pathology, Keck School of Medicine of the University of Southern California

Paul Diehl, Ph.D., COO, Cellecta, Inc.

Jennifer Dien Bard, Director, Clinical Microbiology Laboratory, Assistant Professor, Clinical Pathology, Keck School of Medicine of the University of Southern California

Eric Dishman, Director, Precision Medicine Initiative Cohort Program, NIH

Ronald Dixon, M.D., Director, Virtual Practice Project, Massachusetts General Hospital

Alexander Dobrovic, Head/Group Leader, Translational Genomics, Olivia Newton-John Cancer Research Institute

Dylan Dodd, M.D., Ph.D., Assistant Professor, Pathology and Clinical Fellow, Sonnenburg Lab, Department of Microbiology and Immunology, Stanford University School of Medicine

Lukas Edward Dow, Assistant Professor, Medicine, Weill Cornell Medicine

Paul Drain, M.D., MPH, FACP, Assistant Professor, Global Health, Medicine, and Epidemiology, University of Washington

Ronald P. Dudek, Ph.D., President, Living Pharmaceuticals, Inc.

David Duffy, Massachusetts Vice President, Research and Chief Technology Officer, Quanterix Corporation

Eric Duncavage, M.D., Assistant Professor, Pathology & Immunology, Washington University School of Medicine (AMP 2016 Training & Education Committee, Member)

Mark Edinger, Scientific Advisor, Flow Cytometry, Q Squared

Laura L. Elnitski, Ph.D., Principal Investigator, Genomic Functional Analysis, National Human Genome Research Institute

Kenneth Emancipator, M.D., Executive Medical Director, Translational Medicine, Companion Diagnostics, Merck & Co.

Daniel Emerling, Ph.D., Senior Vice President, Research, Atreca, Inc.

Rajyasree (Raj) Emmadi, M.D., Associate Professor, Clinical Pathology, Pathology, University of Illinois, Chicago (AMP Professional Relations Committee, Member)

Hesaam Esfandyarpour, Ph.D., Founder and CEO, Genapsys

Mark Evans, Associate Director, Technology Innovation & Bioinformatics, XOMA (US) LLC

Muller Fabbri, M.D., Ph.D., Assistant Professor, Pediatrics and Molecular Microbiology & Immunology, Pediatric Hematology/Oncology, Children’s Hospital Los Angeles - University of Southern California

Denise Faustman, M.D., Ph.D., Director, Immunobiology & Associate Professor, Medicine, Immunobiology, Massachusetts General Hospital/Harvard Medical School

Phillip G. Febbo, M.D., CMO, Genomic Health, Inc.

John Feder, Ph.D., Associate Director, Genome Biology and Emerging Technologies, Department of Genetically Defined Diseases and Genomics, Bristol-Myers Squibb

Bonnie Feldman, D.D.S., MBA, Digital Health Analyst and Chief Growth Officer, DrBonnie360

Christof Fellmann, Ph.D., Postdoctoral Fellow, Laboratory of Dr. Jennifer Doudna, Department of Molecular and Cell Biology, University of California, Berkeley

Helen Fernandes, Ph.D., Director, Molecular Pathology, Pathology & Laboratory Medicine, Weill Cornell Medical College

Joseph Ferrara, President, Boston Healthcare

Sean Ferree, Ph.D., Vice President, Diagnostic Development, Nanostring Technologies, Inc.

Andrea Ferreira-Gonzalez, Ph.D., Professor and Chair, Division of Molecular Diagnostics; Director, Molecular Diagnostics Laboratory, Pathology, Virginia Commonwealth University

Kyle Fetter, MBA, Vice President & General Manager, Diagnostic Services Operations, MDx Support Services, XIFIN, Inc.

Andrew C. Fish, J.D., Executive Director, AdvaMedDx

Bernard A. Fox, Ph.D., Providence Cancer Center

Mark Frasier, Senior Vice President, Research Programs, Michael J. Fox Foundation for Parkinson’s Research

Gordon J. Freeman, Ph.D., Professor, Medicine, Division of Hematologic Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School

Morganna Freeman, D.O., Associate Director, Melanoma and Cutaneous Oncology Program, The Angeles Clinic and Research Institute

Bruce Freimark, Ph.D., Research Director, Pre-Clinical Oncology, Peregrine Pharmaceuticals, Inc.

Birgit H. Funke, Ph.D., FACMG, Associate Professor, Pathology, MGH/Harvard Medical School; Director, Clinical Research and Development, Laboratory for Molecular Medicine, Partners HealthCare

Marcial García-Rojo, Ph.D., Head, Pathology Department, Hospital de Jerez de la Frontera, Ronda de Circunvalación

Omai Garner, Ph.D., D(ABMM), Assistant Professor, Pathology and Laboratory Medicine, UCLA

Arnold Gelb, Global Head, Companion Diagnostic Development & US Site Head, EMD Serono

Christian Gerdes, Ph.D., Head, Pharmacology, Roche Pharma Research & Early Development, Roche

Noa Ghersin, Analyst, Lux Research, Inc.

Soma Ghosh, Ph.D., Scientific Reviewer, FDA/CDRH/OIR/DMGP

David Gilbert, M.D., Infectious Diseases, Providence Portland Medical Center

Jason L. Gillman, MS, Director, Precision Genomics, Intermountain Healthcare

Eric F. Glassy, M.D., FCAP, Medical Director, Affiliated Pathologists Medical Group

Harry Glorikian, Healthcare Consultant

Gustavo Glusman, Ph.D., Principal Scientist, Institute for Systems Biology

Ajay Goel, Ph.D., Professor and Director, Center for Gastrointestinal Research, and Director, Center for Epigenetics, Cancer Prevention and Cancer Genomics, Baylor Research Institute, Baylor University Medical Center

Andrew K. Godwin, Ph.D., Chancellors Distinguished Chair, Biomedical Sciences and Endowed Professor, Professor and Director of Molecular Oncology, Pathology and Laboratory Medicine; Deputy Director, The University of Kansas Cancer Center; Director, Biospecimen Shared Resource Kansas Bioscience Authority; Eminent Scholar, University of Kansas Medical Center

Jeffrey A. Golden, M.D., Ramzi S. Cotran Professor & Head, Pathology, Brigham & Women’s Hospital

Ted Goldstein, Ph.D., University of California, Santa Cruz

Wayne W. Grody, M.D., Ph.D., Professor, Medical Genetics and Molecular Pathology, Pathology & Lab Medicine, Pediatrics, Human Genetics, Director, Molecular Diagnostic Laboratories and Clinical Genomics Center, University of California Los Angeles School of Medicine

Jeremy R. Graff, Ph.D., CSO and Senior Vice President, Research, Biothera Pharmaceuticals, Inc.

Stacy Wang Gray, M.D., Assistant Professor, Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School

Jonathan Groberg, MBA, Executive Director, UBS Investment Research

Vinita Gupta, Ph.D, Scientist, Cancer Immunotherapy, Genentech

Dexter Hadley, M.D., Ph.D., Assistant Professor, Pediatrics, Institute for Computational Health Sciences, University of California, San Francisco

Tina Hambuch, Ph.D., FACMG, Medical Director, Pediatric Genetics

Juergen Hammer, Ph.D., MBA, Global Head Data Science, Pharma Research and Development Informatics, Roche Innovation Center New York

John Hanna, Vice President, Marketing & Managed Care, Veracyte, Inc.

Erol Harvey, Ph.D., CEO, MiniFAB

David Haussler, Ph.D., Professor of Biomolecular Engineering, UC Santa Cruz & Scientific Director, UC Santa Cruz Genomics Institute

Trevor Hawkins, Ph.D., Entrepreneur in Residence, GE Ventures

Madhuri Hegde, Ph.D., Professor, Executive Director, Emory Genetics Lab

Karen A. Heichman, Ph.D., Vice President, Director, PharmaDx Program, ARUP Laboratories; Pathology, University of Utah

Dan Heller, CEO, Two Pore Guys, Inc.

Peera Hemarajata, M.D., Ph.D., D(ABMM), Clinical Instructor, Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles

John Ho, M.D., Corporate Senior Vice President & Chief Strategy Officer, Charles River

Courtney Hodges, Ph.D., Biophysics, Department of Pathology, Stanford University School of Medicine

Kevin Holden, Ph.D., Head, Synthetic Biology, Synthego

Shuguang Huang, Ph.D., CSO, Stat4ward LLC

Jim Hugget, Ph.D., Senior Lecturer, Analytical Microbiology, School of Bioscience and Medicine, Faculty of Health and Medical Science, University of Surrey

Jessica Ezzell Hunter, MS Ph.D., Assistant Investigator, Center for Health Research, Kaiser Permanente Northwest

John Hunter, Ph.D., Site Head and Vice President, Antibody R&D, Compugen USA, Inc.

Patrick Hurban, Ph.D., Senior Director and Global Head, Translational Genomics, Q Squared Solutions

Hatim Husain, M.D., Physician, Medical Oncology, University of California, San Diego

Ralf Huss, M.D., CMO, Definiens

Janna Hutz, Ph.D., Senior Director, Head, Human Biology & Data Science Engine, Eisai AiM Institute, Eisai, Inc.

Oleg Iartchuk, Ph.D, Head of Genomics and NGS, Novartis Institutes for BioMedical Research, Inc.

Scott Jackson, Ph.D., Molecular Genetics and Microbial Genomics, National Institute of Standards and Technology

Siddhartha Jaiswal, M.D., Ph.D., Research Fellow and Staff Pathologist, Massachusetts General Hospital and Harvard University; Broad Institute, MIT

Filip Janku, M.D., Ph.D., Assistant Professor, Investigational Cancer Therapeutics (Phase I Program), MD Anderson Cancer Center

Sarah Javaid, Ph.D., Senior Scientist, Discovery Pharmacogenomics, Genetics and Pharmacogenomics, Merck & Co., Inc.

Stefanie Jeffrey, M.D., John and Marva Warnock Professor, Surgery; Chief, Surgical Oncology Research, Stanford University School of Medicine

Shidong Jia, Ph.D., Founder & CEO, Predicine

Fuguo Jiang, Ph.D., Damon Runyon Research Fellow, Laboratory of Dr. Jennifer Doudna, Department of Molecular and Cell Biology, University of California, Berkeley

Douglas B. Johnson, Ph.D., Assistant Professor, Medicine, Vanderbilt University Medical Center

Karin Jooss, Ph.D., CSO, Gritstone Oncology

Christian Jurinke, Ph.D., Managing Director, STRATEC Molecular GmbH

Michael Kalos, M.D., CSO, Cancer Immunobiology, Eli Lilly

Purna C. Kashyap, MBBS, Assistant Professor of Physiology and Assistant Professor of Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic

David Kaufman, Executive Director, Translational Immunology & Oncology, Merck

Mark A. Kay, M.D., Ph.D., Dennis Farrey Family Professor, Departments of Pediatrics and Genetics, Vice Chair for Basic Research (Pediatrics), Stanford University

Anthony R. Kerlavage, Ph.D., Chief, Cancer Informatics Branch, National Cancer Institute, Center for Biomedical Informatics & Information Technology

Purvesh Khatri, Ph.D., Assistant Professor, Medicine, Stanford University

Hamid Khoja, Ph.D., Principal Scientist, Research & Development, Covaris Inc.

Alison Kim, Ph.D., Senior Director, Research and Innovation, American Gastroenterological Association (AGA)

Ryan Kim, Ph.D., Director, Korean Bioinformatics Center (KOBIC), Korea Research Institute of Bioscience & Biotechnology (KRIBB)

Stephen F. Kingsmore, MB, ChB, BAO, DSc, FRCPath, President and CEO, Rady Pediatric Genomics & Systems Medicine Institute, Rady Children’s Hospital, San Diego

Donald Klepser, Pharm.D., MBA, Associate Professor, Pharmacy Practice, University of Nebraska Medical Center

Hans Klingemann, M.D., Ph.D., Vice President, Research & Development, NantKwest, Inc.

Walter H. Koch, Ph.D., Vice President, Global Research, Roche Molecular Systems

Padma Kodukula, Ph.D., Senior Director, Business Development, Human Longevity, Inc.

Andreas M. Kogelnik, M.D., Ph.D., Open Medicine Institute

Eric Konnick, M.D., MS, FCAP, Acting Assistant Professor, Associate Director, Genetics and Solid Tumor Laboratory Department of Laboratory Medicine University of Washington

Farida Kopti, Ph.D., Director, Chemistry/Pharmacology/HTS Informatics IT, Merck Research Labs, Merck & Co.

Gerald J. Kost, M.D., Ph.D., M.S., FACB, Director, POC Testing Center for Teaching and Research (POCT•CTR), Pathology and Laboratory Medicine, School of Medicine, University of California, Davis

Paul Kotturi, Ph.D., PacBio

Susan Kretz, MT (ASCP), Manager, Point-of-Care Testing, PCL Alverno Clinical Labs

Joel Krier, M.D., MMSc, Clinical Chief, Division of Genetics; Director, Brigham Genomic Medicine, Brigham and Women’s Hospital; Instructor, Harvard Medical School

Peter Krein, Ph.D., Managing Director, Diaceutics

Raga Krishnakumar, Ph.D., Bioinformatics, Sandia National Laboratories

Raj Krishnan, Ph.D., California CEO, Biological Dynamics

Shashikant Kulkarni, Ph.D., Professor, Molecular and Human Genetics; Co-Vice Chair, Research, Molecular and Human Genetics, Baylor College of Medicine; CSO, Baylor Miraca Genetics Laboratories; Vice President, Operations, Baylor Miraca Genetics Laboratories (AMP Member)

Frank C. Kuo, M.D., Ph.D., Director, Assay Development, Center for Advanced Molecular Diagnostics, Department of Pathology, Brigham and Women’s Hospital

Thomas S. Kupper, M.D., Chair, Dermatology, Brigham and Women’s Hospital; Dana Farber Cancer Institute; Thomas B. Fitzpatrick Professor, Harvard Medical School

Vinayak Kulkarni, Bioinformatics Software Engineer, Invitae

Vinod Kumar, Ph.D., Senior Scientific Investigator, Computational Biology (US), Target Sciences, R&D, GSK

Winston Kuo, D.M.Sc., President, Predicine Holdings, Ltd.

Joshua M. Lang, M.D., MS, Assistant Professor, Medicine, Carbone Cancer Center, University of Wisconsin

Martin Leach, Vice President R&D IT, Enterprise Data Management & Analytics, IT, Alexion Pharmaceuticals

Nathan A. Ledeboer, Ph.D., Associate Professor, Pathology, Medical College of Wisconsin

Dean Anthony Lee, M.D., Ph.D., Professor, Pediatrics; Director, Cellular Therapy and Cancer Immunotherapy Program, Nationwide Children’s Hospital; James Comprehensive Cancer Center/Solove Research Institute, The Ohio State University

Hyeyong Lee, Ph.D., Professor, Biomedical Laboratory Science, Yonsei University, Wonju Campus

L. James Lee, Professor, Chemical and Biomolecular Engineering, The Ohio State University

John Leite, Ph.D., Vice President, Oncology, Market Development & Product Marketing, Illumina, Inc.

Monkol Lek, Ph.D., Research Fellow, Massachusetts General Hospital

Emil Lesho, DO, FACP, FIDSA, FSHEA, Infectious Disease Physician, Healthcare Epidemiologist, Infectious Diseases, Rochester Regional Health

Lei Li, Ph.D., Assistant Professor, Mechanical and Materials Engineering, Washington State University

Wei Li, Ph.D., Associate Professor, Division of Biostatistics, Duncan L. Cancer Center-LI, Baylor College of Medicine

Yun Li, Head, R&D Informatics, R&D Business Technology, Pfizer San Francisco

Han Liang, Ph.D., Associate Professor and Deputy Chair, Department of Bioinformatics and Computational Biology, Associate Professor, Department of Systems Biology, The University of Texas MD Anderson Cancer Center

John Liddicoat, Ph.D., Philomathia Research Fellow, Faculty of Law, University of Cambridge

Changchun Liu, Ph.D., Research Assistant Professor, Department of Mechanical Engineering and Applied Mechanics, University of Pennsylvania

Sean Liu, Ph.D., Global Head, Translational Science Systems, Research IT, Takeda Pharmaceuticals

Christina Lockwood, Ph.D., DABCC, FACB, Assistant Professor, Department of Laboratory Medicine; Associate Director, Genetics and Solid Tumor Diagnostics Laboratory, University of Washington (AMP Member)

Chengzu Long, Ph.D., Assistant Professor, Division of Cardiology, New York University School of Medicine

Bryan Loy, M.D., MBA, Vice President, Oncology, Laboratory, and Personalized Medicine, Health Guidance Organization, Humana

Ira M. Lubin, Ph.D., FACMG, Division of Laboratory Systems/CSELS, Office of Public Health Scientific Service, The Centers for Disease Control and Prevention

Jason J. Luke, M.D., FACP, Assistant Professor, Medicine, Melanoma and Developmental Therapeutics Clinics, University of Chicago

Raja Luthra, Ph.D., Professor, Hematopathology, The University of Texas MD Anderson Cancer Center

Philip C. Mack, Ph.D., Associate Adjunct Professor, Internal Medicine, Hematology and Oncology, University of California, Davis Medical Center

Hisani Madison, Ph.D. MPH, Scientific Reviewer, Division of Molecular Genetics and Pathology, Office of In Vitro Diagnostics and Radiological Health, Center for Devices and Radiological Health, U.S. Food and Drug Administration

Kathleen M. Mahoney, M.D., Ph.D., Clinical Instructor, Beth Israel Deaconess Medical Center; Research Fellow, Dana-Farber Cancer Institute

G. Mike Makrigiorgos, Ph.D., Professor, Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School

Prashant Mali, Ph.D., Assistant Professor, Department of Bioengineering, University of California San Diego

Elizabeth A. Mansfield, Ph.D., Director, Personalized Medicine, Office of in vitro Diagnostics & Radiological Health, FDA CDRH (pending approval)

Rong Mao, M.D., FACMG, Medical Director, Molecular Genetics and Genomics, ARUP Laboratories; Assistant Professor, Pathology, University of Utah School of Medicine

Scott Martin, Senior Scientific Manager, Group Lead, Functional Genomics, Discovery Oncology, Genetech

Stuart S. Martin, Ph.D., Associate Professor, Physiology, Greenebaum NCI Cancer Center, University of Maryland School of Medicine

Raquel Marie Martinez, Ph.D., D(ABMM), Director, Clinical and Molecular Microbiology, Laboratory Medicine, Geisinger Health System

Laurence J. Marton, M.D., Member, Board of Trustees, American Association for Cancer Research Foundation; Member, Board of Directors, Cancer Commons

Matt Marton, Ph.D., RAC, Director, Genomics and Companion Diagnostics, Translational Biomarkers, Merck & Co., Inc.

Joanne Mason, Ph.D., Director of Sequencing and Sample Acquisition, Genomics England, Queen Mary University of London

Marielena Mata, Ph.D., Head, Precision Medicine, GlaxoSmithKline

Andreas Matern, Vice President, Partnerships & Innovation, BioReference Laboratories, GeneDX

Kurt Matthes, Vice President, RCM Reengineering and Service, Revenue Cycle Management, TELCOR, Inc.

John Mattison, M.D., Assistant Medical Director, Chief Medical Information Officer, Kaiser Permanente, SCAL

Emeran Mayer, M.D., Ph.D., Executive Director, Oppenheimer Center for Stress and Resilience and Co-Director, Digestive Diseases Research Center, University of California at Los Angeles; Author, The Mind-Gut Connection: How the Hidden Conversation Within Our Bodies Impacts Our Mood, Our Choices, and Our Overall Health (published July 2016)

Ian McCaffery, Ph.D., Vice President, Translational Sciences, Corvus Pharmaceuticals

Patricia McCoon, Ph.D., Principal Scientist, Oncology Translational Science, AstraZeneca Pharmaceuticals

Dawn McHugh, Director, Precision Diagnostics & Pharma Partnering, QIAGEN

Robert J. Meagher, Ph.D., Principal Member, Biotechnology and Bioengineering, Sandia National Laboratories

Annette Meredith, Ph.D., Color Genomics, Inc. (AMP Informatics Subdivision Representative to the AMP Global 2017 Organizing Committee)

Jason Merker, M.D., Ph.D., Co-Director of the Stanford Medicine Clinical Genomics Service, Pathology, Stanford University School of Medicine

Michael Messenger, Ph.D., Head of Personalised Medicine and Health, University of Leeds; Deputy Director, NIHR Diagnostic Evidence Co-operative Leeds

Bradley Messmer, Ph.D., CEO, Abreos Biosciences, Inc.

James Michaelson, Ph.D., Director, Laboratory of Quantitative Medicine, Member, Pathology and Surgery, Massachusetts General Hospital; Associate Professor, Harvard University

Jennifer Michaelson, Ph.D., Executive Program Leader and Senior Director, Preclinical Development, Jounce Therapeutics

Tore Midtvedt, M.D., Ph.D., Professor, Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet

Jeffrey Miller, M.D., Professor, Medicine; Deputy Director, Masonic Cancer Center; Roger L. and Lynn C. Headrick Chair in Cancer Therapeutics, University of Minnesota

Steve Miller, M.D., Ph.D., Director, UCSF Clinical Microbiology Laboratory, Laboratory Medicine, University of California San Francisco

Andrew J. Mills, Senior Director, Sponsor Solutions, FIRECREST, ICON plc

Susan Mockus, Ph.D., Manager, Clinical Analytics & Curation, The Jackson Laboratory for Genomic Medicine

Carl Morrison, M.D., DVM, President, CSO & Founder, OmniSeq Precision Medicine

Jennifer J.D. Morrissette, Ph.D., Clinical Director, Center for Personalized Diagnostics, University of Pennsylvania

Iva Morse, CSO, Vice President, Charles River

Peter Mouritzen, Vice President, Research & Development, Exiqon

Spyro Mousses, Ph.D., President, Systems Imagination, Inc.

Pamela N. Munster, M.D., Professor, Medicine, Program Leader, Development Therapeutics, Director, Early Phase Clinical Trials Program, Helen Diller Cancer Center, University of California, San Francisco

Mark Musen, M.D., Ph.D., Professor, Biomedical Informatics at Stanford University, Director of the Stanford Center for Biomedical Informatics Research

James Musser, M.D., Ph.D., Professor of Pathology and Genomic Medicine, Institute for Academic Medicine, Houston Methodist

Lincoln D. Nadauld, M.D., Medical Director, Cancer Genomics, Intermountain Healthcare

Arun Nayar, Executive Director, R&D IS, Amgen

Peter S. Nelson, M.D., Professor, Medicine, Division of Oncology, Fred Hutchinson Cancer Research Center

Thomas Neuwerth CQA(ASQ), MB(ASCP)CM, Quality Assurance, Intermountain Precision Genomics

Ruslan Novosiadly, Senior Research Advisor, Cancer Immunobiology, Biomarkers, Eli Lilly

Mark E. Nunes, M.D., Associate Professor, Pediatrics, Division Chief, Medical Genetics, Kaiser Permanente

Keith Nykamp, Ph.D., Senior Scientist, Clinical Genomics Group, Invitae

Brian O’Connor, Technical Director, Analysis Core Genomics Institute, UCSC

Cece O'Connor, Global Director, UX Strategy & Design, Invetech

Julia Oh, Ph.D., Assistant Professor, The Jackson Laboratory

Landon Olp, Ph.D., Research & Development, Scientist, Immunology & Biomarkers, Streck

Maynard V. Olson, Ph.D., Professor Emeritus, Medicine and Genome Sciences, University of Washington

Mai-Britt Worm Orntoft, Student, Molecular Medicine, Aarhus University Hospital Skejby

Reinhard Ortmann, Director, Companion Diagnostics, QIAGEN

Gabriel Otte, Ph.D., CEO, Co-Founder, Freenome, Inc.

Nitika Pant Pai, M.D., MPH, Ph.D., Associate Professor, Medicine, Divisions of Clinical Epidemiology & Infectious Diseases, McGill University

Alfred Papali, M.D., Assistant Professor, Pulmonary & Critical Care Medicine, Institute for Global Health, University of Maryland School of Medicine

Liron Pantanowitz, M.D., Associate Professor, Pathology, University of Pittsburgh Medical Center Conference Chairman

Klaus Pantel, M.D., Professor and Founding Director, Institute of Tumor Biology, University, Medical Center Hamburg-Eppendorf

Pamela Paris, Ph.D., Professor, Urology, University of California, San Francisco

Yoav Peretz, Ph.D., Scientific Director, Caprion Biosciences, Inc. (Formerly ImmuneCarta Services Inc.)

Noah Wolcott Palm, Ph.D., Assistant Professor of Immunobiology, Human and Translational Immunology Program, Yale University School of Medicine

Abhijit Patel, M.D., Ph.D., Assistant Professor, Yale University School of Medicine

Kamlesh Patel, Ph.D., Manager, Advance Systems Engineering and Deployment, Sandia National Labs

Sandip Patel, M.D., Assistant Professor, Cancer Immunotherapy Program, Experimental Therapeutics, Thoracic Oncology; Assistant Director, Clinical Trials Office, Medicine/Hematology & Oncology, University of California, San Diego Moores Cancer Center

Aristides A.N. Patrinos, Ph.D., Senior Adviser, United States Secretary of Energy and Programs and Policy Advisor, Synthetic Genomics Inc.

Scott D. Patterson, Ph.D., Vice President, Biomarker Sciences, Gilead Sciences, Inc.

Rudi Pauwels, Ph.D., Founder & CEO, Biocartis

Cloud P. Paweletz, Ph.D., Head, Translational Research Laboratory; Biomarker Lead, Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute

John Pfeifer, M.D., Ph.D., Vice Chair, Clinical Affairs, Pathology, Washington University School of Medicine

William Pignato, Founder and Principal, W. J. Pignato & Associates

German Pihan, M.D., Director, Hematopathology Lab, Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School

Tom Plasterer, Ph.D., Director, US Cross-Science, AstraZeneca

Jamie Platt, Ph.D., Managing Director, BRIDGenomics, LLC

Christopher R. Polage, M.D., MAS, Director, Clinical Microbiology Laboratory, Associate Professor of Clinical Pathology and Infectious Diseases, Pathology and Laboratory Medicine, University of California, Davis Health System

Victoria M. Pratt, Ph.D., FACMG, Director, Pharmacogenomics Laboratory, Department of Medical and Molecular Genetics, Indiana University School of Medicine (AMP Professional Relations Committee, Member)

Frederic I. Preffer, Ph.D., Director, Flow Cytometry, Pathology, Massachusetts General Hospital; Associate Professor, Pathology, Harvard Medical School

Corrado Priami, Professor & CEO, The Microsoft Research - University of Trento COSBI

Nathan Price, Ph.D., Professor & Associate Director, Institute for Systems Biology

Colin Pritchard, M.D., Ph.D., Associate Professor, Laboratory Medicine, University of Washington

Pascal Puchois, Ph.D., CEO, Trans-Hit Biomarkers

Girish Putcha, M.D., Ph.D., Director, Laboratory Science, Palmetto GBA (MolDX)

April Pyle, Ph.D., Associate Professor, Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles

Ping Qiu, Ph.D., Translational Molecular Biomarkers (TMB), Genomics, Merck Research Laboratories

Paul Radensky, M.D., Principal, McDermott+Consulting; Partner, McDermott Will & Emery

Deepak K. Rajpal, Ph.D., Director, Computational Biology-Target Sciences, GSK

Babar K. Rao, M.D., FAAD, Clinical Professor, Dermatology, Robert Wood Johnson Medical School, Rutgers University

Debra J. Rasmussen, MBA, Global Regulatory Affairs Diagnostic Leader, Janssen Pharmaceuticals

David L. Rimm, M.D., Ph.D., Professor, Pathology, Yale University

Rosana Risques, Ph.D., Assistant Professor, Pathology, University of Washington

Dan M. Roden, M.D., Professor, Medicine, Pharmacology, and Biomedical Informatics; Director, Oates Institute for Experimental Therapeutics; Senior Vice President for Personalized Medicine, Vanderbilt University Medical Center

Michael H. A. Roehrl, M.D., Ph.D., Director, Precision Pathology Biobanking Center, Memorial Sloan Kettering Cancer Center

Mark J. Routbort, M.D., Ph.D., Associate Professor, MD Anderson Cancer Center (AMP Informatics Subdivision Representative to the AMP 2017 Clinical Practice Committee)

Somak Roy, M.D., Assistant Professor, Director, Genetic Services and Molecular Informatics; Assistant Director, Molecular and Genomic Pathology Laboratory, University of Pittsburgh Medical Center (AMP Informatics Subdivision Representative to the AMP 2017 Program Committee)

Krishanu Saha, Ph.D., Assistant Professor, Department of Biomedical Engineering, & Wisconsin Institute for Discovery, University of Wisconsin, Madison

Rangarajan Sampath, Ph.D., Senior Research Fellow and Senior Director, R&D, Ibis Biosciences, Abbott

Rebecca Sanders, Ph.D., Researcher, Molecular Biology, Science and Innovation, LGC

Neville Sanjana, Ph.D., Core Faculty Member, New York Genome Center and Assistant Professor, Department of Biology & Center for Genomics and Systems Biology, New York University

Avni Santani, Ph.D., Director, Division of Genomic Diagnostic, The Children’s Hospital of Philadelphia; Assistant Professor, Clinical Pathology and Laboratory Medicine, University of Pennsylvania

Tharini Sathiamoorthy, Vice President, AdvaMedDx

Kurt A. Schalper, M.D., Ph.D., Assistant Professor, Pathology and Medicine (Medical Oncology), Yale School of Medicine; Director Translational Immuno-oncology Laboratory, Yale Cancer Center

Travis Schlappi, Student, Chemical Engineering, California Institute of Technology

Karsten Schmidt, Ph.D., CTO, Trovagene

Lawrence B. Schook, Ph.D., Gutsgell Professor, Animal Sciences and Radiology, University of Illinois

Nicholas Schork, Ph.D., Director, Human Biology, Professor, J. Craig Venter Institute

Richard Schoske, GS-15, Ph.D., Chief, Diagnostics, Detection and Threat Surveillance Div (CBA), Chemical and Biological Technologies Department (J9/CB), Defense Threat Reduction Agency

Sid Scudder, M.D., Senior Director, Clinical Science, Genomics & Oncology, Roche Molecular Systems

Robert P. Sebra, Ph.D., Director, Technology Development, Icahn Institute of Genomics & Multiscale Biology; Associate Professor, Genetics & Genomics, Icahn School of Medicine at Mount Sinai

Ajay Shah, Director, Research Informatics and Systems, Office of Chief Informatics Officer, Beckman Research Institute, City of Hope National Medical Center

Nigam Shah, Ph.D., Associate Professor of Medicine (Biomedical Informatics), Stanford University, Assistant Director, The Center for Biomedical Informatics Research

Julie Shaw, Ph.D., Assistant Professor, Department of Pathology and Laboratory Medicine at The University of Ottawa - The Ottawa Hospital

Kenna R. Mills Shaw, Ph.D., Executive Director, Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personal Cancer Therapy (IPCT)

Henry Schek, Ph.D., Chief Technical Officer, Chroma Technology Corp

Christopher Shelton, Ph.D., Manager, Immuno-Oncology & Combinations DPU, Oncology R&D, GlaxoSmithKline

Maria Shevchuk, M.D., Associate Professor, Pathology & Lab Medicine, Weill Cornell Medical College, Cornell University

Jeff Shrager, Ph.D., CTO, Cancer Commons

Stephanie Shulman, MPH, MS, MT (ASCP), Director, Clinical Laboratory Evaluation Program, Wadsworth Center, New York State Department of Health (pending approval)

Martin Siaw, Ph.D., MB(ASCP)CM, Vice President of Science and Innovation, BasePrime Genomics, Senior Technical Consultant, BRIDGenomics

Tara Sigdel, Ph.D., Assistant Professor, Department of Surgery, University of California, San Francisco

Marc Siladi, Senior Business Analyst, Core Informatics

Deborah Siler, Ph.D., Senior Research Associate, Mouse Genetics, Genetech

Mark Simpson, Ph.D., Senior Scientist, Laboratory of Cancer Biology and Genetics, National Cancer Institute

Peter Sims, Ph.D., Assistant Professor, Systems Biology, Columbia University Medical Center

Mallika Singh, Ph.D., Oncology Pharmacology, ORIC Pharmacology

Stan Skrzypczak, Vice President, Corporate Development and Reimbursement, Guardant Health, Inc.

George W. Sledge, M.D., Professor, Medicine; Chief, Division of Oncology, Stanford University School of Medicine

Philippe Slos, Director, Scientific Operations, Operations, Oncodesign

Joshua T. Smith, Ph.D., Research Staff Member, Translational Systems Biology and Nanobiotechnology, IBM T. J. Watson Research Center

Dan Snyder, MBA, President & CEO, MolecularMD

Nara Lygia de Macena Sobreira, M.D., Assistant Professor, Genetic Medicine, McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University

Kai Sohn, Ph.D., Group Leader, MBT, Fraunhofer IGB

Sneha Somasekar, BS, Staff Research Associate, Chiu Laboratory and UCSF-Abbott Viral Diagnostics and Discovery Center, University of California, San Francisco

Paul M. Sondel, M.D., Ph.D., Reed and Carolee Walker Professor of Pediatrics and Human Oncology; Head, Division of Pediatric Hematology, Oncology and BMT; University of Wisconsin

Steven A. Soper, Ph.D., Foundation Distinguished Professor, Department of Chemistry, Department of Mechanical Engineering; Director, Center of BioModular Multi-Scale System for Precision Medicine, The University of Kansas

Jorge Soto, CTO, Miroculus

Pieter Spee, CTO, FibroTx LLC

Nathan Standifer, Ph.D., Scientist II, Clinical Pharmacology and DMPK, MedImmune

Louis M. Staudt, M.D., Ph.D., Director, Center for Cancer Genomics, Co-Chief, Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health

John Strickler, M.D., Assistant Professor, Medicine, Duke University Medical Center

Gregory Storch, M.D., Ruth L. Siteman Professor, Pediatrics, Washington University School of Medicine

Liping Laura Sun, Ph.D., Principal Scientific Researcher, Translational Oncology, Genentech, Inc.

Keiichiro Suzuki, Ph.D., Research Associate, Laboratory of Dr. Juan Carlos Izpisua Belmonte, Gene Expression Laboratory, The Salk Institute for Biological Studies

Pamela Swatkowski, Director, Regulatory Affairs, Abbott Molecular

Fraser Symmans, Ph.D., M.D., Professor and Director, Research Operations Department of Pathology Anderson Cancer Center

Zoltan Szallasi, Ph.D., M.D., Senior Research Scientist, Children’s Hospital Informatics Program, Children’s Hospital Boston, Harvard Medical School; Assistant Professor, Pediatrics, Harvard Medical School; Assistant Professor, Pediatrics, Boston Children’s Hospital

Rachel Tam, Senior Scientific Researcher, Oncology Biomarker Development, Genentech

Min-Han Tan, Ph.D., Principal Investigator, Biodevices and Diagnostics, Institute of Bioengineering and Nanotechnology

Janis M. Taube, M.D., Associate Professor, Dermatology, Pathology, and Oncology; Director, Dermatopathology Division and Fellowship, Johns Hopkins University School of Medicine

J. Marty Tenenbaum, Ph.D., Chairman, Cancer Commons

Jan ter Meulen, M.D., Dr.habil., DTM&H, CSO, Immune Design

Jason Terrell, M.D., CMO, VolitionRx

Gavin Thurston, Vice President, Oncology and Angiogenesis Research, Regeneron Pharmaceuticals

Judi Tilghman, Ph.D., Vice President, Technology Assessment, Quidel

John E. Tomaszewski, M.D., MASCP, Professor and Chair, Pathology and Anatomical Sciences, School of Medicine and Biomedical Sciences, State University of New York, Buffalo

Weida Tong, Ph.D., Director, Division of Bioinformatics and Biostatistics, NCTR/FDA

Deanna Tran, Pharm.D., BCACP, Assistant Professor, Pharmacy Practice and Science, University of Maryland School of Pharmacy

Martin Treder, Ph.D., CSO, Affimed

Frédéric Triebel, M.D., Ph.D., CSO & CMO, Prima BioMed Ltd.

Dana W. Y. Tsui, Ph.D., Assistant Attending Geneticist; Member, Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center

Katherine Tynan, Ph.D., Business Development & Strategic Consulting for Diagnostics Companies, Tynan Consulting LLC

Bob Uger, Ph.D., CSO, Trillium Therapeutics Inc.

Mickey S. Urdea, Ph.D., Founder, Partner, Halteres Associates, LLC

Gerrit Van Roekel, Senior Program Officer, Business Development, Bill & Melinda Gates Foundation

Michael van Waes, Ph.D., Director, Molecular Products, Molecular Technology, Streck

Bernard Vanhove, Ph.D., COO, OSE Immunotherapeutics

Karl V. Voelkerding, M.D., Professor, Pathology, University of Utah; Medical Director for Genomics and Bioinformatics, ARUP Laboratories

Jeffrey Wallin, Ph.D., Group Leader and Senior Scientist, Oncology Biomarker Development, Genentech, Inc.

Kai Wang, Ph.D., Associate Professor, Biomedical Information, Institute for Genomic Medicine, Columbia University

Kai Wang, Ph.D., Principal Scientist, Institute for Systems Biology

Alistair J. Watt Ph.D., Q2 Solutions

Bernhard H. Weigl, Principal Investigator, Flow Based Diagnostics, Intellectual Ventures/Global Good, Affiliate Professor, Department of Bioengineering, University of Washington

Victor Weigman, Ph.D., Director, Translational Genomics, Q2 Solutions

Larry Weiss, M.D., CMO, AOBiome, LLC

Wendy A. Wells, M.D., MSc, The E. Elizabeth French Professor and Chair, Pathology and Laboratory Medicine, Geisel School of Medicine at Dartmouth; Vice President, Pathology and Laboratory Medicine Service Line, Dartmouth-Hitchcock Medical Center

Max S. Wicha, M.D., Madeline and Sidney Forbes Professor, Oncology; Founding Director Emeritus, University of Michigan Comprehensive Cancer Center

David C. Wilbur, M.D., Professor, Pathology, Massachusetts General Hospital

Chris Williams, M.D., Senior Lecturer, Informatics, Department of Pathology, University of Michigan

Monte Winslow, Ph.D., Assistant Professor, Genetics, Stanford University

David T.W. Wong, D.M.D., DMSc, University of California Los Angeles, Felix & Mildred Yip Endowed Professor & Associate Dean of Research, School of Dentistry, Director, Center for Oral/Head & Neck Oncology Research

Elizabeth Worthey, Ph.D., Faculty Investigator, Clinical Informatics Director, and Adjunct Associate Professor, Software Development and Informatics, Pediatrics and Genetics, HudsonAlpha Institute for Biotechnology

Joseph C. Wu, M.D., Ph.D., Director, Stanford Cardiovascular Institute, Professor, Medicine & Radiology, Stanford University School of Medicine

Lin Wu, Ph.D., Vice President, Development, Roche

Ken H. Young, M.D., Ph.D., Professor, Hematopathology, The University of Texas MD Anderson Cancer Center

David Yu, Ph.D., Group Leader, Molecular Core, Translational Medicine, Genocea Biosciences

Jianda Yuan, M.D., Ph.D., Director, Translational Immuno-Oncology Research, Early Clinical Oncology Development, Merck & Co., Inc.

Peng Yue, Associate Director, Research Bioinformatics, Gilead Sciences

Dale Yuzuki, MA, M.Ed, Director, Market Development – Oncology, SeraCare Life Sciences

Jesse Zaretsky, UCLA-Caltech Medical Scientist Training Program, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles

Bing Zhang, Ph.D., Professor, Department of Molecular and Human Genetics, Lester & Sue Smith Breast Center, Baylor College of Medicine

Mengmeng Zhang, Research Fellow, Wyss Institute, Harvard University

Theresa Zhang, Ph.D., Vice President, Research Services, Personal Genome Diagnostics

Weian Zhao, Ph.D., Assistant Professor, Department of Pharmaceutical Sciences, Sue and Bill Gross Stem Cell Research Center, Chao Family Comprehensive Cancer Center, Edwards Lifesciences Center for Advanced Cardiovascular Technology, Department of Biomedical Engineering, University of California, Irvine

Wenyan Zhong, Ph.D., Senior Principal Scientist, Oncology R&D Group, Pfizer

Xianghong Jasmine Zhou, Ph.D., Professor, Pathology and Laboratory Medicine, University of California, Los Angeles

Jennifer Ziello, Senior Research Associate, Translation Diagnostics, Cell Signaling

Bernhard Zimmermann, Ph.D., Senior Director, Research & Development, Natera

Amado Zurita-Saveedra, M.D., Associate Professor, MD Anderson

Prof, Bioengineering, Pennsylvania State Univ